Biotechnology company Moderna has announced a major settlement to resolve global patent litigation with Arbutus Biopharma Corporation and Genevant Sciences GmbH over technology used in its mRNA vaccines. The agreement settles all ongoing lawsuits worldwide related to the companies’ disputes.

The Ministry of Health, Labour and Welfare (MHLW) in Japan has granted orphan drug designation to rilzabrutinib, a novel, oral, reversible covalent Bruton’s tyrosine kinase (BTK) inhibitor, for IgG4-related disease (IgG4-RD).

Glenmark Specialty SA has received final approval from the U.S. Food and Drug Administration for Fluticasone Propionate Inhalation Aerosol USP

The regulator has announced that companies will now receive the No Objection Certificate, NOC more quickly, helping to streamline regulatory procedures and reduce approval timelines.

D.Pharm plus two Years experience in relevant subject/field. Managing Ocular Surface Disorders, Randomized Trials on Dry Eye Disease and Meibomian Gland Dysfunction

M.Sc /M. Tech. in Life Sciences or related natural science disciplines. Lethal Aortopathy syndrome associated with novel FBLN4D203A Mutation among Mappila Children of Malabar, Kerala - seeking novel clinical, molecular genetic and anthropological insights.

M.Pharm in Pharmaceutics / Pharmacology or any other equivalent Degree. Previous research/industry experience in exosome formulation and development, animal handling skills.

Post-graduate degree (M.Sc./MS) in Life Sciences, Clinical Chemistry ; M.Tech. in Biomedical Engineering/ Bioengineering/ Biotechnology/ Medical Devices.

B.Pharm or D.Pharm from a recognized university. Registered with Indian Nursing council or Pharmacist Council of India with 2 years of experience post qualification. All India Institute of Medical Sciences (AIIMS) Bhopal

M.Tech./M.Pharm./MBA/M.Phil. or M.Sc./B.Pharm. or an equivalent degree with a minimum of 60 percent aggregate in the qualifying examination

A Diploma in Pharmacy or Bachelor of Pharmacy or Pharm.D. District Health Society of Chengalpattu

The Manager - IT CSV is responsible for end-to-end oversight of Computerized System Validation, equipmen/ utility qualifications, audit support, and quality systems compliance in a GxP-regulated pharmaceutical environment.

Program Manager- R&D Transformation & Productivity, you will play a key role in supporting the execution of strategic transformation initiatives across the global R&D organization. Dr. Reddys Laboratories

M.Pharm / M.S.Pharm / M.Tech with specialization in Pharmaceutics, Biotechnology, Medical Devices, Nanomedicine or equivalent. GPAT, GATE, NET will be preferred.

Diploma / Certificate in Ayurveda Pharmacist Course recognized by the Govt. of State.

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies in the world.

First-class post-graduate degree (M.Sc./MS) in Life Sciences, (M. Tech.) in Biomedical Engineering / Bioengineering / Biotechnology / Medical Devices

Looking for enthusiastic fresher candidates for production activities in the Manufacturing Department, who are eager to start and grow their career in the pharmaceutical industry.

Support Medical Affairs objectives for assigned Cardio-Diabetes / Specialty therapies in emerging markets. Provide scientific and clinical inputs using current guidelines, clinical data, and real-world evidence.